Genomic Nantijen Diagnostics Limited is a healthcare company based in Hong Kong, we operate in worldwide under two divisions: Biopharmaceuticals and Diagnostics. 

​

Genomic Nantijen Diagnostics researches, develops, manufactures bacterial and viral diagnostic kits, reagents, reference standards for research and medical diagnostic applications. Internally, it is organized into two business divisions:

​

Biopharmaceuticals Biologics:

• Vaccines (Viral Vaccines, Bacterial Vaccines, Conjugate Vaccines, Viral Particles, DNA and RNA Based Vaccines).

• Novacell proprietary Platform Technology for making affordable, timely available and readily accessible vaccines with the highest titers and purest quality standards

• R& D, Process Development, Scale-up and Clinical Development                                                                                                 

Diagnostics (CLIA, CAP, ISO & Medical Research Centers)

• Molecular Diagnostics; RT-PCR, RNA, DNA PCR

• Tissue Diagnostics                                                                                    

All business areas focus on health care applications, targeting physicians, hospitals, government contracts, clinics, or consumers. Life Science targets research settings in academia and pharmaceutical and biotechnology industries.